Precipio PRPO 深 沪
已收盘 10-16 16:00:00 美东时间
21.375
-1.165
-5.17%
华盛通- 最 高22.50
- 今 开22.29
- 成交量 9.51万股
- 最 低 21.375
- 昨 收 22.54
- 总市值 3826.53万
- 52周最高 33.63
- 市盈率 静 --
- 换手率 5.31%
- 52周最低 18.50
- 委 比 -98.02%
- 总股本 179.02万
- 历史最高 8448.00
- 量 比 3.13
- 振 幅 4.99%
- 历史最低 3.90
- 每 手 1
- 风险率 2.77%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Precipio Inc收跌5.17%，成交额207.62万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:36
Precipio Q2 2026 Earnings Call: Complete Transcript
Precipio (NASDAQ:PRPO) held its second-quarter earnings conference call on Monday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts, visit https://www.benzinga.com/apis/. The full earnings call is available at ...
09-18 19:59
Precipio reports Q2 results
Precipio press release (PRPO): Q2 Revenue of $7M (+22.8% Y/Y). Adjusted EBITDA – $0.4M vs. $(0.2)M in Q1-2026. Cash flow - Cash Flow generated from operations was $0.7M in Q2-2026; total increase in c...
08-17 15:40
Precipio Q2 EPS $(0.12) Down From $0.05 YoY, Sales $7.021M Up From $5.654M YoY
Precipio (NASDAQ:PRPO) reported quarterly losses of $(0.12) per share. This is a 340 percent decrease over earnings of $0.05 per share from the same period last year. The company reported $7.021 million in sales this quarter. This is a 24.18 percent increase over sales of $5.654 million the same per...
08-15 04:39
Precipio Announces Q2-2026 Financial Results
Precipio, a specialty cancer diagnostics company, reported strong financial results for Q2-2026, with revenue reaching $7.0M, a 22% year-over-year increase. Adjusted EBITDA turned positive at $0.4M, up from -$0.2M in Q1-2026, driven by higher revenues and reduced stock-based compensation. Cash flow improved, ending the quarter with over $3M in cash, up from $1.1M in Q2-2025. CEO Ilan Danieli highlighted the company's operational strength and conf...
08-14 20:00
Precipio Schedules Q2 2026 Shareholder Update Call
Precipio ( ($PRPO) ) has issued an announcement. On July 31, 2026, New Haven-ba...
08-01 05:21
Precipio Announces Q2-2026 Shareholder Update Call
Precipio, Inc. will host a Q2-2026 shareholder update call on August 17, 2026, at 5:00 PM ET. The call will cover the company’s current core businesses and include a live Q&A session. CEO Ilan Danieli expressed excitement about Q2 results, highlighting progress in customer acquisition, pipeline expansion, and business growth. Investors can submit questions in advance via email to investors@precipiodx.com or participate during the call by dialing ...
07-31 20:00
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
Precipio, Inc. (NASDAQ: PRPO), a specialty cancer diagnostics company, is urging shareholders to instruct their brokers to vote their shares by June 14, 2026, at 11:59 p.m. Eastern Time, to ensure a quorum for its Annual Meeting on June 15, 2026. Currently, approximately 42% of shares have been voted, and at least 50% are needed to hold the meeting. If insufficient votes are received, the meeting may need to be adjourned and reconvened, resulting...
06-12 17:00
Precipio to Present at the Planet MicroCap Las Vegas
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) will present at the Planet MicroCap Las Vegas 2026 conference on June 17, 2026, at 9:00 AM local time (12:00 PM EST) at the Bellagio Resort & Hotel. CEO Ilan Danieli and COO Zaki Sabet will host the presentation and answer questions. Precipio aims to expand its shareholder base and raise awareness rather than seek capital. The live presentation and registration details are availab...
06-11 21:00
Precipio Q1 EPS $(0.81) Down From $(0.59) YoY, Sales $6.711M Up From $4.929M YoY
Precipio (NASDAQ:PRPO) reported quarterly losses of $(0.81) per share. This is a 37.29 percent decrease over losses of $(0.59) per share from the same period last year. The company reported $6.711 million in sales this
05-15 05:03
